Stock market crash: Here are the stocks I’d buy if equities collapse in September

We don’t know if another stock market crash is imminent but it is good to be prepared. Buying low is the best way for shareholders to pick up bargains.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Since the stock market crash in March, investors have been wondering if another one is imminent. The rebound in equity markets lately does not match with the economic fallout of the Covid-19 pandemic, and this is making shareholders nervous.

Stock market crash or correction

A market correction differs slightly from a crash. A crash is a dramatic decline of stock prices on a single day, whereas a correction is when a financial index falls over 10% below its most recent high and can last days, weeks, or months.

The European Union’s securities watchdog warns a sustained correction is likely. This is because recovery, and a bounce back to a pre-pandemic economy, is likely to take a very long time. The International Monetary Fund expects the eurozone GDP to fall over 10% this year, with slow recovery next year. For this reason, a September stock market crash is not out of the question, but I’m no psychic, so will have to wait and see. I think it’s best to prepare for every eventuality, and as a long-term value investor, keeping core principles in mind is a good place to start.

Dividend-paying stocks

I want to benefit from the power of dividend compounding and long-term growth. To do this I search for stocks that are likely to go the distance and make a sustained recovery from market lows. Companies falling into this category, in my view, include BAE Systems (LSE:BA), GlaxoSmithKline, and Royal Dutch Shell.

As geopolitical tensions rise and technology advances, cyber-crime is an increasing threat. This makes me think defence is a good sector to invest in. BAE Systems regularly wins international government contracts, and I think this will continue. Concern surrounding government defence spending has been suppressing the BAE share price in recent months, but in the long term I think spending will increase. The UK is already looking at ways to divert budgets to defence and intelligence, and other governments may follow suit.

BAE’s technological advancements are not only impressive but vital in ensuring high-calibre solutions for aerospace, defence, and security markets. Interpol recently released a report warning that cybercriminal activity has increased amid Covid-19. Russia and China have been accused of hacking, and fake news is on the rise. All this points to a need for continued investment in national security. BAE recently reinstated its dividend which has a yield of 4.5%. Earnings per share are 46.4p and its price-to-earnings ratio (P/E) is 11.

Diversified sectors

GlaxoSmithKline is a science-led pharmaceutical giant creating medicines and vaccines, including a Covid-19 vaccine in partnership with Sanofi. It’s a £75bn company that continues to pay a dividend with a current yield of 5.4%. Earnings per share for the trailing 12 months sit at £1.32 and, based on this, GSK’s P/E is 11.

Now, we all know renewables are the future of energy, but oil remains indispensable in reaching that eventuality. Royal Dutch Shell has been around for decades and I believe it has the knowledge, experience, and budgets to continue to profit and adapt in this changing environment. I think it’s a sensible long-term buy and at 4.6%, it offers a decent dividend yield.

There are many companies that have thrived since the last stock market crash and I would begin my research by looking to those as potential buys in the next one.

Kirsteen owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature black woman at home texting on her cell phone while sitting on the couch
Investing Articles

Could this cheap FTSE 100 stock be the next Rolls-Royce?

Paul Summers casts his eye over a battered-but-high-quality FTSE 100 stock. Is this the next top-tier company to stage a…

Read more »

ISA Individual Savings Account
Investing Articles

Hesitant over a Stocks and Shares ISA? Here’s a way to deal with scary markets

Volatile stock markets are scaring potential investors away from getting started with their first Stocks and Shares ISA in 2026.

Read more »

This way, That way, The other way - pointing in different directions
Market Movers

Standard Life’s announced a £2bn deal but its share price is largely unchanged. Why?

James Beard considers why the Standard Life share price didn’t take off today (15 April) after the group announced it…

Read more »

Happy parents playing with little kids riding in box
Investing Articles

Up 12% in a month, Hollywood Bowl is a UK dividend stock on a roll

This 5%-yielding dividend stock was one of the top performers in the FTSE 250 index today. What sent it flying…

Read more »

Close-up of children holding a planet at the beach
Investing Articles

Young investors are taking the stock market on a rollercoaster ride. Here’s how retirees can buckle up

Mark Hartley reveals the volatile impact that younger investors are having on the stock market and how UK retirees can…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

£7,500 invested in Aviva shares 5 years ago is now worth…

A lump sum pumped into Aviva shares half a decade ago has grown a lot. Andrew Mackie looks at the…

Read more »

Young female hand showing five fingers.
Investing Articles

Could £20,000 invested in these 5 dividend shares produce £14,760 of passive income over the next 10 years?

James Beard considers the potential of dividend shares to deliver amazing levels of passive income. Here are five that have…

Read more »

Workers at Whiting refinery, US
Investing Articles

At 570p, is it too late to consider buying BP shares?

Since the end of February, when the conflict in the Middle East started, BP shares have soared nearly 20%. But…

Read more »